✦ LIBER ✦

Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials?

✍ Scribed by Pietro Majno; Emiliano Giostra; Gilles Mentha

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 127 KB
Volume: 13
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21328

No coin nor oath required. For personal study only.

✦ Synopsis

Francisco; RFTA, radiofrequency thermal ablation; TACE, transarterial chemoembolization; UNOS, United Network for Organ Sharing. This article is based on a review of the treatment of hepatocellular carcinoma while patients are on a liver transplant waiting list that our group published in Journal of Hepatology in 2005, and a similar text was provided in the manual of the 7th International Meeting on Therapy Liver Diseases, Barcelona, Spain, September 12-14, 2007. Although new concepts and references have been added, the views of the group are substantially unchanged, and similarities in the publications are unavoidable.

📜 SIMILAR VOLUMES

Transplantation for hepatocellular carci

Transplantation for hepatocellular carcinoma: Management of patients on the waiting list

✍ Pietro Majno; Gilles Mentha; Christian Toso; for the Geneva Liver Cancer Study G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

In discussing the mananagement of patients in the waiting list, the terms neoadjuvant treatment, bridging, downstaging and dropout should be used consistently, and on the basis of accepted selection criteria (currently MC, incorporated into the tumor-nodemetastasis [TNM] staging system as follows: T

Tools for monitoring patients with hepat

Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation

✍ Norman Kneteman; Tito Livraghi; David Madoff; Eduardo de Santibañez; Michael Kew 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

For patients who are initially being listed for liver transplantation and for patients who are seeking to retain their active status on the wait list, the first step in the diagnostic consideration of hepatocellular carcinoma (HCC) is the accurate identification and staging of the tumors. Advances i

Ablation therapy in containing extension

Ablation therapy in containing extension of hepatocellular carcinoma: A simulative analysis of dropout from the waiting list for liver transplantation

✍ Noriyo Yamashiki; Ryosuke Tateishi; Haruhiko Yoshida; Shuichiro Shiina; Takuma T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

The dropout from the waiting list for liver transplantation among patients with hepatocellular carcinoma (HCC) is reportedly as high as 12% to 40% per year, mostly due to tumor progression. Considering the scarcity of donor organs, it would be beneficial if we could retain them within the Milan crit